AA
GOSS icon

ALPS Advisors’s Gossamer Bio GOSS Stock Holding History

ALPS Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-99,155
Closed -$261K – 1031
2025
Q3 		$261K Sell
99,155
-23,489
-19% -$51.8K ﹤0.01% 1000
2025
Q2 		$151K Buy
+122,644
New +$134K ﹤0.01% 1017
2022
Q2 		– Sell
-78,603
Closed -$682K – 1058
2022
Q1 		$682K Sell
78,603
-9,884
-11% -$95.3K 0.01% 358
2021
Q4 		$1M Sell
88,487
-4,649
-5% -$55.2K 0.01% 359
2021
Q3 		$1.17M Sell
93,136
-6,845
-7% -$63K 0.01% 373
2021
Q2 		$812K Sell
99,981
-37,390
-27% -$324K 0.01% 429
2021
Q1 		$1.27M Buy
137,371
+310
+0.2% +$3.13K 0.01% 372
2020
Q4 		$1.32M Buy
137,061
+40,357
+42% +$398K 0.01% 360
2020
Q3 		$1.2M Sell
96,704
-6,654
-6% -$88.2K 0.02% 320
2020
Q2 		$1.34M Sell
103,358
-16,701
-14% -$210K 0.02% 270
2020
Q1 		$1.22M Sell
120,059
-13,000
-10% -$170K 0.02% 252
2019
Q4 		$2.08M Buy
133,059
+1,638
+1% +$33K 0.02% 223
2019
Q3 		$2.21M Sell
131,421
-6,504
-5% -$129K 0.02% 206
2019
Q2 		$3.06M Buy
+137,925
New +$2.64M 0.02% 189

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ALPS Advisors's GOSS Position: Q4 2025 in Review

ALPS Advisors sold out of Gossamer Bio (GOSS) in Q4 2025, closing a stake of 99,155 shares — an estimated $261K sold.

ALPS Advisors first reported a position in GOSS in Q2 2019 and held it in 14 quarters. The position peaked at $3.06M in Q2 2019. 195 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

  • ALPS Advisors reported no remaining Gossamer Bio position as of Q4 2025 after selling out during the quarter.
  • ALPS Advisors sold 99,155 Gossamer Bio shares in Q4 2025, an estimated $261K.
  • ALPS Advisors first reported a position in Gossamer Bio in Q2 2019 and held it in 14 quarters.
  • ALPS Advisors's Gossamer Bio position peaked at $3.06M in Q2 2019.
  • 195 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on ALPS Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.